Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-10-18Clinical Trial Update: Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies [Phase 1, Phase 2]
Clinical trial update investigating the combination of apatinib and S-1 for recurrent/metastatic head and neck cancers (Phase 1/2).
-
CLINICAL_TRIALS research · 2018-10-12Clinical Trial Update: A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer [NA]
Clinical trial evaluating molecular targets of vorinostat in patients with aerodigestive tract cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating erlotinib in combination with cisplatin for recurrent or metastatic head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-02Clinical Trial Update: Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating bevacizumab and erlotinib in recurrent or metastatic head and neck squamous cell carcinoma has completed…
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head & Neck Cancer [Phase 2]
Phase 2 trial evaluating topical ketamine mouthwash for analgesia in patients undergoing chemoradiation or radiotherapy for head and neck ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC [Phase 2]
A Phase 2 randomized trial evaluating capecitabine treatment in patients with head and neck neoplasms.
-
CLINICAL_TRIALS research · 2018-08-21Clinical Trial Update: A Prospective Study Evaluating the Use of Intraoperative Stroke Volume Variation Via the FloTrac Device to Guide Fluid and Vasopressor Management in Head and Neck Free Flaps [NA]
A completed clinical trial assessing intraoperative stroke volume variation guidance using FloTrac to manage fluids and vasopressors in head…
-
CLINICAL_TRIALS trial_result · 2018-08-20Clinical Trial Update: Comparing Palliative Radiotherapy With or Without Carboplatin [Phase 3]
A Phase 3 trial comparing palliative radiotherapy with or without carboplatin in patients with lung cancer and head and neck cancer was term…
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040) [Phase 3]
Phase 3 trial comparing pembrolizumab to standard treatment for recurrent or metastatic head and neck cancer has completed with results post…
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating nab-paclitaxel, cisplatin, and cetuximab with concurrent radiation therapy for locally advanced head and neck can…
-
CLINICAL_TRIALS withdrawal · 2018-07-20Clinical Trial Update: Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation [Phase 2, Phase 3]
A Phase 2/3 trial comparing PET imaging tracers F-18 FLT and F-18 FDG for treatment evaluation in head and neck cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas [Phase 2]
A Phase 2 clinical trial update evaluating the antiangiogenic agent anlotinib in patients with recurrent/metastatic head and neck adenocarci…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Iodine I 131 in Treating Patients With Thyroid Cancer [NA]
The Johns Hopkins-sponsored trial evaluating radioactive iodine I-131 for thyroid cancer was terminated, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating the combination of gemcitabine and doxorubicin in patients with recurrent or progressive head and neck cancer; resu…
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Perioperative Gabapentin Use In Head And Neck Mucosal Surgery Patients [Phase 4]
Phase 4 trial update on perioperative gabapentin use in head and neck mucosal surgery patients with completed status and posted results in 2…
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx [Phase 3]
A Phase 3 trial from the European Organisation for Research and Treatment of Cancer evaluating combination chemotherapy plus radiation thera…
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated adding lapatinib to chemoradiation in patients with locally advanced laryngeal or hypopharyngeal cancer…
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer [Phase 3]
This Phase 3 trial updates on combining chemotherapy with radiation therapy for advanced head and neck cancer. The study status is completed…
-
CLINICAL_TRIALS withdrawal · 2018-07-09Clinical Trial Update: Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery [Phase 2]
This ClinicalTrials.gov entry reports that the Phase 2 trial evaluating cetuximab with chemotherapy and radiation for newly diagnosed stage …
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Reliability and Validity of Patient Reported Outcome Measures in Head and Neck Cancer
A Mayo Clinic-led clinical trial assessed the reliability and validity of patient-reported outcome measures in head and neck cancer; the stu…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery [EARLY_Phase 1]
An early-phase 1 trial evaluated erlotinib in patients with head and neck cancer that could be removed by surgery. The study assesses safety…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy [NA]
This clinical trial evaluating esophagoscopy to evaluate treatment in stage I-IV head and neck cancer patients receiving radiation and/or ch…
-
FDA approval · 2018-07-02FDA Approved: DOCETAXEL — Original Application (Mylan Institutional LLC)
FDA approved an original application for a generic docetaxel product (docetaxel anhydrous) from Mylan Institutional LLC. The generic is an i…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Ketogenic Diet Phase 1 for Head & Neck Cancer [NA]
A Phase 1 trial evaluating a ketogenic diet for head and neck cancer has been terminated.
-
CLINICAL_TRIALS other · 2018-06-08Clinical Trial Update: Salvage Brachytherapy and Hyperthermia for Recurrent H&N-tumours [NA]
This clinical trial is evaluating salvage brachytherapy and hyperthermia for locally recurrent head and neck cancer. The study is currently …